Share-based Payment Arrangement, Expense of Xenetic Biosciences, Inc. from 31 Mar 2015 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Xenetic Biosciences, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Mar 2015 to 30 Sep 2025.
  • Xenetic Biosciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $16,000, a 43% decline year-over-year.
  • Xenetic Biosciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $104,000, a 29% decline year-over-year.
  • Xenetic Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $200,000, a 33% decline from 2023.
  • Xenetic Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $300,000, a 40% decline from 2022.
  • Xenetic Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $500,000, a 25% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Xenetic Biosciences, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $104,000 $16,000 -$12,000 -43% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $116,000 $16,000 -$26,000 -62% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $142,000 $19,000 -$58,000 -75% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $200,000 $53,000 +$53,000 01 Oct 2024 31 Dec 2024 10-K 18 Mar 2025 2024 FY
Q3 2024 $147,000 $28,000 -$72,000 -72% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 $219,000 $42,000 -$58,000 -58% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q2
Q1 2024 $277,000 $77,000 -$23,000 -23% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q4 2023 $300,000 $0 -$200,000 -100% 01 Oct 2023 31 Dec 2023 10-K 18 Mar 2025 2024 FY
Q3 2023 $500,000 $100,000 $0 0% 01 Jul 2023 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $500,000 $100,000 $0 0% 01 Apr 2023 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $500,000 $100,000 $0 0% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $500,000 $200,000 +$100,000 +100% 01 Oct 2022 31 Dec 2022 10-K 21 Mar 2024 2023 FY
Q3 2022 $400,000 $100,000 $0 0% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $400,000 $100,000 $0 0% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 $400,000 $100,000 $0 0% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $400,000 $100,000 -$11,869 -11% 01 Oct 2021 31 Dec 2021 10-K 22 Mar 2023 2022 FY
Q3 2021 $411,869 $100,000 -$10,799 -9.7% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022 2022 Q3
Q2 2021 $422,668 $100,000 -$11,734 -11% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2
Q1 2021 $434,402 $100,000 -$65,598 -40% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q4 2020 $500,000 $111,869 -$11,117 -9% 01 Oct 2020 31 Dec 2020 10-K 22 Mar 2022 2021 FY
Q3 2020 $511,117 $110,799 -$136,638 -55% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021 2021 Q3
Q2 2020 $647,755 $111,734 -$137,420 -55% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $785,175 $165,598 -$68,342 -29% 01 Jan 2020 31 Mar 2020 10-Q 11 May 2021 2021 Q1
Q4 2019 $853,517 $122,986 -$133,520 -52% 01 Oct 2019 31 Dec 2019 10-K 16 Mar 2021 2020 FY
Q3 2019 $987,037 $247,437 -$76,041 -24% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020 2020 Q3
Q2 2019 $1,063,078 $249,154 -$196,455 -44% 01 Apr 2019 30 Jun 2019 10-Q 12 Aug 2020 2020 Q2
Q1 2019 $1,259,533 $233,940 -$172,254 -42% 01 Jan 2019 31 Mar 2019 10-Q 14 May 2020 2020 Q1
Q4 2018 $1,431,787 $256,506 -$44,731 -15% 01 Oct 2018 31 Dec 2018 10-K 26 Mar 2020 2019 FY
Q3 2018 $1,476,518 $323,478 +$21,487 +7.1% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019 2019 Q3
Q2 2018 $1,455,031 $445,609 -$78,259 -15% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019 2019 Q2
Q1 2018 $1,533,290 $406,194 -$259,803 -39% 01 Jan 2018 31 Mar 2018 10-Q 13 May 2019 2019 Q1
Q4 2017 $1,793,093 $301,237 -$288,219 -49% 01 Oct 2017 31 Dec 2017 10-K 29 Mar 2019 2018 FY
Q3 2017 $2,081,312 $301,991 -$314,942 -51% 01 Jul 2017 30 Sep 2017 10-Q 09 Nov 2018 2018 Q3
Q2 2017 $2,396,254 $523,868 -$1,207,935 -70% 01 Apr 2017 30 Jun 2017 10-Q 10 Aug 2018 2018 Q2
Q1 2017 $3,604,189 $665,997 +$379,537 +132% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018 2018 Q1
Q4 2016 $3,224,652 $589,456 +$290,060 +97% 01 Oct 2016 31 Dec 2016 10-K 30 Mar 2018 2017 FY
Q3 2016 $2,934,592 $616,933 -$1,440,586 -70% 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017 2017 Q3
Q2 2016 $4,375,178 $1,731,803 +$1,641,833 +1825% 01 Apr 2016 30 Jun 2016 10-Q 14 Aug 2017 2017 Q2
Q1 2016 $2,733,345 $286,460 +$139,232 +95% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017 2017 Q1
Q4 2015 $2,594,113 $299,396 01 Oct 2015 31 Dec 2015 10-K 31 Mar 2017 2016 FY
Q3 2015 $2,057,519 01 Jul 2015 30 Sep 2015 10-Q 14 Nov 2016 2016 Q3
Q2 2015 $89,970 01 Apr 2015 30 Jun 2015 10-Q 15 Aug 2016 2016 Q2
Q1 2015 $147,228 01 Jan 2015 31 Mar 2015 10-Q 16 May 2016 2016 Q1

Xenetic Biosciences, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $200,000 -$100,000 -33% 01 Jan 2024 31 Dec 2024 10-K 18 Mar 2025 2024 FY
2023 $300,000 -$200,000 -40% 01 Jan 2023 31 Dec 2023 10-K 18 Mar 2025 2024 FY
2022 $500,000 +$100,000 +25% 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2024 2023 FY
2021 $400,000 -$100,000 -20% 01 Jan 2021 31 Dec 2021 10-K 22 Mar 2023 2022 FY
2020 $500,000 -$353,517 -41% 01 Jan 2020 31 Dec 2020 10-K 22 Mar 2022 2021 FY
2019 $853,517 -$578,270 -40% 01 Jan 2019 31 Dec 2019 10-K 16 Mar 2021 2020 FY
2018 $1,431,787 -$361,306 -20% 01 Jan 2018 31 Dec 2018 10-K 26 Mar 2020 2019 FY
2017 $1,793,093 -$1,431,559 -44% 01 Jan 2017 31 Dec 2017 10-K 29 Mar 2019 2018 FY
2016 $3,224,652 +$630,539 +24% 01 Jan 2016 31 Dec 2016 10-K 30 Mar 2018 2017 FY
2015 $2,594,113 01 Jan 2015 31 Dec 2015 10-K 31 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.